<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>FDA Clinical Decision Support Software vs. EU&rsquo;s Medical Device Regulation | MoFo Life Sciences</title>
<meta name="description" itemprop="description" content>
<meta name="description" itemprop="keywords" content>
<link rel="canonical" href="https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation">


																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					<meta property="og:description" content="In+follow-up+to+our+colleagues+recent+post+about+the+newly+implemented+Medical+Device+Regulation+%28%26ldquo%3BMDR%26rdquo%3B%29+in+the+European+Union%2C+this+post+will+discuss+some+of+the+similarities+between+FDA%26rsquo%3Bs+Clinical+Decision+Support+%28%26ldquo%3BCDS%26rdquo%3B%29+Software+Draft+Guidance+%28together+the+%26ldquo%3BCDS+Draft+Guidance%26rdquo%3B%29+and+the+MDR.">
<meta property="og:url" content="https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html">
<meta property="og:site_name" content="MoFo Life Sciences">
<meta property="og:image" content="https://media2.mofo.com/images/mofolifesciences-medical-devices.jpg">
<meta property="og:locale" content="en_US">



<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="single single-post postid-574142711 single-format-standard full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=574142711";_q+="&7=3262841";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=574142711";_qc+="&7=3262841";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=574142711&amp;7=3262841&amp;25=0&amp;18=0.10852148081926716">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="MoFo Life Sciences" rel="home">
                                	                                	MoFo Life Sciences
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Because No One is Immune to the Law</span>
                                </div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn active">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_20.html">AI + Robotics</a>
		 	<a href="topics_5.html">Agtech</a>
		 	<a href="topics.html">Announcements</a>
		 	<a href="topics_2.html">Antitrust</a>
		 	<a href="topics_13.html">Asia</a>
		 	<a href="topics_9.html">Bioinformatics</a>
		 	<a href="topics_27.html">Biotech</a>
		 	<a href="topics_30.html">Blockchain</a>
		 	<a href="topics_6.html">CFIUS</a>
		 	<a href="topics_4.html">COVID-19</a>
		 	<a href="topics_16.html">Corporate + Venture Capital</a>
		 	<a href="topics_10.html">Data Analytics</a>
		 	<a href="topics_11.html">Digital Health</a>
		 	<a href="topics_23.html">Employment</a>
		 	<a href="topics_31.html">European Union</a>
		 	<a href="topics_18.html">FDA</a>
		 	<a href="topics_12.html">Financing</a>
		 	<a href="topics_29.html">Global</a>
		 	<a href="topics_21.html">Healthcare</a>
		 	<a href="topics_24.html">Intellectual Property</a>
		 	<a href="topics_3.html">Licensing + Commercial</a>
		 	<a href="topics_15.html">Litigation</a>
		 	<a href="topics_25.html">Medical Devices + Diagnostics</a>
		 	<a href="topics_17.html">Pharma</a>
		 	<a href="topics_19.html">Privacy + Data Security</a>
		 	<a href="topics_14.html">Product Liability + Class Action</a>
		 	<a href="topics_7.html">Rare Disease</a>
		 	<a href="topics_1.html">Regulatory</a>
		 	<a href="topics_26.html">Startup</a>
		 	<a href="topics_28.html">United Kingdom</a>
		 	<a href="topics_22.html">United States</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div>
    
    
    


<script>
function printPage() {
  window.print();
}
</script>



<div class="content_container">
    <section class="content_wrap row" role="document">
        <div id="content" class="medium-8 large-8 columns" role="main">
            <article id="post-574142711" class="post-574142711 post type-post status-publish format-standard has-post-thumbnail hentry category-foreign-corrupt-practices-act">
                <header class="entry-header">
                    <div class="row blog-header">
                        <div class="columns medium-7 rockwell pms-7702c">
                            <em>April 6, 2021</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a>, <a href="topics_1.html" rel="category tag">Regulatory</a>, <a href="topics_22.html" rel="category tag">United States</a>
                        </div>
                        <div class="columns medium-5 social-jet">
                            <div class="sharedaddy sd-sharing-enabled">
                                <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                    <h3 class="sd-title">Share This</h3>
                                            <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html&amp;title=FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation&amp;summary=In follow-up to our colleagues recent post about the newly implemented Medical Device Regulation (MDR) in the European Union, this post will discuss some of the similarities between FDAs Clinical Decision Support (CDS) Software Draft Guidance (together the CDS Draft Guidance) and the MDR.&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_152.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=MoFo Life Sciences&amp;body=FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation - https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                            </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <h1 class="entry-title">
                        FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation</h1>
                </header>
                <!-- .entry-header -->
                <div class="entry-meta">
                    <div class="blog-author-meta subheader">			
                                                

                                                                    </div>
                </div>
                <div class="entry-content">
                                    <img width="300" class="alignright" src="https://media2.mofo.com/images/mofolifesciences-medical-devices.jpg">
                                        <p>In follow-up to our colleagues recent <a target="_blank" href="Software-as-Medical-Device-in-Europe-New-Reg-Regime-to-Enter-into-Force-Part-3.html">post</a> about the newly implemented Medical Device Regulation (&ldquo;MDR&rdquo;) in the European Union, this post will discuss some of the similarities between FDA&rsquo;s Clinical Decision Support (&ldquo;CDS&rdquo;) Software Draft <a target="_blank" href="https://www.fda.gov/media/109618/download">Guidance</a> (together the &ldquo;CDS Draft Guidance&rdquo;) and the MDR.&nbsp;</p>
<p>While still in draft form, we note that FDA has <a target="_blank" href="https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/cdrh-proposed-guidances-fiscal-year-2021-fy-2021">signaled its intent</a> to finalize the CDS Draft Guidance in 2021.</p>
<h4>Statutory Framework</h4>
<p>Under the current CDS Draft Guidance, FDA first bases its approach to CDS on criteria set forth in the 21st Century Cures Act (the &ldquo;Cures Act&rdquo;). Excluded from the definition of a &ldquo;device&rdquo; under the Cures Act are software functions that met all four of the following criteria:</p>
<p>(1) not intended to acquire, process, or analyze a medical image or a signal from an in vitro diagnostic device or a pattern signal from a signal acquisition system;</p>
<p>(2) intended for the purpose of displaying, analyzing, or printing medical information about a patient or other medical information (such as peer-reviewed clinical studies and clinical practice guidelines);</p>
<p>(3) not intended for the purpose of supporting or providing recommendations to a health care professional about prevention, diagnosis, or treatment of a disease or condition; and</p>
<p>(4) intended for the purpose of enabling such health care professional to independently review the basis for such recommendations that such software presents so that it is not the intent that such health care professional rely primarily on any of such recommendations to make a clinical diagnosis or treatment decision regarding an individual patient.</p>
<p>Notably, these criteria do not include software functions intended for a patient or caregiver; rather, these criteria apply only to those software functions for &ldquo;health care professionals.&rdquo; Accordingly, software device manufacturers must analyze all software functions utilized by patients and caregivers carefully using the CDS Draft Guidance to determine whether FDA will either exercise its oversight focus, requiring the software to receive FDA approval as a device, or its enforcement discretion.&nbsp;&nbsp;</p>
<h4>IMDRF Framework</h4>
<p>FDA&rsquo;s CDS Draft Guidance also relies on the International Medical Device Regulators Forum (&ldquo;IMDRF&rdquo;) Framework for Software as a Medical Device (&ldquo;SaMD&rdquo;) in approaching its interpretation of the criteria from the statue that would exclude a software from the definition of a medical device. The MDR also utilized this IMDRF framework for SaMD. IMDRF focuses on two factors, which are critical to the analysis of SaMD: (1) whether the user uses the information provided by a SaMD to treat or diagnose, to <i>drive</i> clinical management, or to <i>inform</i> clinical management; and (2) whether the patient&rsquo;s healthcare situation or condition is critical, serious, or non-serious.</p>
<p>The CDS Draft Guidance utilizes the IMDRF framework, and includes a variation of the classification used under Rule 11 by the European Commission&rsquo;s <a href="https://ec.europa.eu/docsroom/documents/37581" target="_blank"><i>Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745-MDR and Regulation (EU) 2017/746-IVDR</i></a>, to similarly categorize different types of SaMD.</p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="156" rowspan="2">
<p align="center">State of healthcare   situation or condition</p>
</td>
<td width="468" colspan="3">
<p align="center">Significance of   information provided by SaMD to</p>
<p align="center">healthcare decision</p>
</td>
</tr>
<tr>
<td width="156">
<p align="center">Treat or</p>
<p align="center">diagnose</p>
</td>
<td width="156">
<p align="center">Drive clinical   management</p>
</td>
<td width="156">
<p align="center">Inform clinical</p>
<p align="center">management</p>
</td>
</tr>
<tr>
<td width="156" valign="top">
<p>Critical</p>
</td>
<td width="156" valign="top">
<p align="center">IV</p>
</td>
<td width="156" valign="top">
<p align="center">III</p>
</td>
<td width="156" valign="top">
<p align="center">II</p>
</td>
</tr>
<tr>
<td width="156" valign="top">
<p>Serious</p>
</td>
<td width="156" valign="top">
<p align="center">III</p>
</td>
<td width="156" valign="top">
<p align="center">II</p>
</td>
<td width="156" valign="top">
<p align="center">I</p>
</td>
</tr>
<tr>
<td width="156" valign="top">
<p>Non-serious</p>
</td>
<td width="156" valign="top">
<p align="center">II</p>
</td>
<td width="156" valign="top">
<p align="center">I</p>
</td>
<td width="156" valign="top">
<p align="center">I</p>
</td>
</tr>
</tbody>
</table>
<p><br>FDA uses the risk-categorizations described above to apply a risk-based policy to its regulation of Device CDS functions.</p>
<h4>Other Components of the CDS Draft Guidance</h4>
<p>In addition to the above framework from IMDRF, the CDS Draft Guidance also focuses on whether the intended user is a healthcare provider or a patient or caregiver and whether the user can independently review the basis for the recommendation from the software.&nbsp;&nbsp;</p>
<p>This focus on user-type and independent review, rooted in the Cures Act language, is a departure from the IMDRF (and the MDR&rsquo;s) framework, which focuses more upon the intended use of the software and the medical conditions the software covers.&nbsp;</p>
<p>As you can see in the table below, FDA has a demonstrated interest in those software functions where the intended user is a patient or caregiver, particularly when the device is informing clinical management for serious or critical healthcare situations or conditions. Similarly, when the intended user is a healthcare provider, FDA does not consider the software to be a device so long as the healthcare provider can independently review the basis for the recommendation.</p>
<p>Combining the IMDRF Framework with FDA&rsquo;s focus on the user-type and whether the user can independently review the basis for the recommendation, results in the following table:</p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="249" colspan="2" valign="top">
<p align="center">&nbsp;</p>
</td>
<td width="125" valign="top">
<p align="center">Intended User is   HCP</p>
</td>
<td width="234" valign="top">
<p align="center">Intended User is   Patient or Caregiver</p>
</td>
</tr>
<tr>
<td width="125" valign="top">
<p align="center">IMDRF Risk   Categorization</p>
</td>
<td width="125" valign="top">
<p align="center">Can the User   Independently Review the Basis?</p>
</td>
<td width="125" valign="top">
<p align="center">FDA Regulation</p>
</td>
<td width="234" valign="top">
<p align="center">FDA Regulation</p>
</td>
</tr>
<tr>
<td width="125" rowspan="2" valign="top">
<p align="center">Inform</p>
<p align="center">x</p>
<p align="center">Critical</p>
</td>
<td width="125">
<p align="center">Yes</p>
</td>
<td width="125">
<p align="center">Not a Device</p>
</td>
<td width="234">
<p align="center">Oversight Focus</p>
</td>
</tr>
<tr>
<td width="125">
<p align="center">No</p>
</td>
<td width="125">
<p align="center">Oversight Focus</p>
</td>
<td width="234">
<p align="center">Oversight Focus</p>
</td>
</tr>
<tr>
<td width="125" rowspan="2" valign="top">
<p align="center">Inform</p>
<p align="center">x</p>
<p align="center">Serious</p>
</td>
<td width="125">
<p align="center">Yes</p>
</td>
<td width="125">
<p align="center">Not a Device</p>
</td>
<td width="234">
<p align="center">Oversight Focus</p>
</td>
</tr>
<tr>
<td width="125">
<p align="center">No</p>
</td>
<td width="125">
<p align="center">Oversight Focus</p>
</td>
<td width="234">
<p align="center">Oversight Focus</p>
</td>
</tr>
<tr>
<td width="125" rowspan="2" valign="top">
<p align="center">Inform</p>
<p align="center">x</p>
<p align="center">Non-Serious</p>
</td>
<td width="125">
<p align="center">Yes</p>
</td>
<td width="125">
<p align="center">Not a Device</p>
</td>
<td width="234">
<p align="center">Enforcement   Discretion</p>
</td>
</tr>
<tr>
<td width="125">
<p align="center">No</p>
</td>
<td width="125">
<p align="center">Enforcement   Discretion</p>
</td>
<td width="234">
<p align="center">Oversight Focus</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<h4>Examples</h4>
<p>The CDS Draft Guidance provides a number of examples where FDA works through its framework. These examples walk through the IMDRF framework while considering the intended user and whether the user can independently review the recommendation from the&nbsp;SaMD.</p>
<p><i>Non-Device CDS</i></p>
<p>FDA considers the following software to not be a device: software that compares patient signs, symptoms, or results with available practice guidelines (institutions-based or academic/clinical society-based) to recommend condition-specific diagnostic tests, investigations, or therapy to healthcare providers. In this example, the software uses practice guidelines as the basis for the recommendation and provides such guidelines to the healthcare provider to review, such that the health care provider does not rely primarily on the software&rsquo;s recommendation.</p>
<p><i>Enforcement Discretion</i></p>
<p>FDA plans to utilize its enforcement discretion on software that assist a patient in identifying an over-the-counter cold or allergy medication to consider purchasing based on symptoms. In this example, the software would include appropriate warnings about products with overlapping ingredients. This software is device CDS because it is intended for a patient; however, FDA does not intend to enforce compliance because the software is intended to provide options to patients for the treatment of a non-serious situation or condition and because the patient can independently review the basis for the software&rsquo;s recommendations.</p>
<p><i>Oversight Focus</i></p>
<p>FDA plans to focus its regulatory oversight on device CDS functions intended for patients, where the software is informing clinical management of serious or critical conditions. For example, FDA intends to regulate the following as device CDS: a software function that recommends when the parent or caregiver of pediatric patients with cystic fibrosis should take a child to the emergency room by aggregating information based on patient-specific symptoms and care guidelines. This software is device CDS because a caregiver uses the software and the software informs clinical management for a critical situation or condition, particularly because of the fragility of the target population.&nbsp; &nbsp;</p>
<h4>Conclusion</h4>
<p>Recognizing that companies with global offerings face a complexity of issues, companies should seek to leverage similarities amongst the regulatory classification of SaMD and CDS. However, companies should simultaneously be acutely attuned to the critical differences in how those frameworks are applied by the applicable regulatory bodies. There is a need for attention to these issues, particularly with the upcoming finalization of the CDS guidance in FY2021 by FDA and the MDR coming into effect on May 26, 2021.</p>
                        <div class="sharedaddy sd-sharing-enabled">
                            <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                <h3 class="sd-title">Share This</h3>
                                        <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html&amp;title=FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation&amp;summary=In follow-up to our colleagues recent post about the newly implemented Medical Device Regulation (MDR) in the European Union, this post will discuss some of the similarities between FDAs Clinical Decision Support (CDS) Software Draft Guidance (together the CDS Draft Guidance) and the MDR.&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_152.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=MoFo Life Sciences&amp;body=FDA Clinical Decision Support Software vs. EU’s Medical Device Regulation - https://lifesciences.mofo.com/topics/FDA-Clinical-Decision-Support-Software-vs-EUs-Medical-Device-Regulation.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                        
                                        </div>
                            </div>
                        </div>
                        <!-- .entry-content -->
                        <footer class="entry-meta">
                            <div class="entry-meta-footer">
                            </div>
                            <!-- end .entry-meta-footer -->
                        </footer>
                        <!-- .entry-meta -->
</div></article>
<!-- #post -->
                </div>
                <!-- #content -->
                <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                                        





<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1457511">AI + Robotics</option>
                                                                                                <option class="level-0" value="1457521">Agtech</option>
                                                                                                <option class="level-0" value="1457691">Announcements</option>
                                                                                                <option class="level-0" value="1462201">Antitrust</option>
                                                                                                <option class="level-0" value="1457531">Asia</option>
                                                                                                <option class="level-0" value="1468521">Bioinformatics</option>
                                                                                                <option class="level-0" value="1456751">Biotech</option>
                                                                                                <option class="level-0" value="1458171">Blockchain</option>
                                                                                                <option class="level-0" value="1458511">CFIUS</option>
                                                                                                <option class="level-0" value="1462211">COVID-19</option>
                                                                                                <option class="level-0" value="1457541">Corporate + Venture Capital</option>
                                                                                                <option class="level-0" value="1458861">Data Analytics</option>
                                                                                                <option class="level-0" value="1465651">Digital Health</option>
                                                                                                <option class="level-0" value="1458521">Employment</option>
                                                                                                <option class="level-0" value="1457551">European Union</option>
                                                                                                <option class="level-0" value="1459381">FDA</option>
                                                                                                <option class="level-0" value="1457561">Financing</option>
                                                                                                <option class="level-0" value="1459511">Global</option>
                                                                                                <option class="level-0" value="1459951">Healthcare</option>
                                                                                                <option class="level-0" value="1457581">Intellectual Property</option>
                                                                                                <option class="level-0" value="1457591">Licensing + Commercial</option>
                                                                                                <option class="level-0" value="1457601">Litigation</option>
                                                                                                <option class="level-0" value="1459061">Medical Devices + Diagnostics</option>
                                                                                                <option class="level-0" value="1457631">Pharma</option>
                                                                                                <option class="level-0" value="1457641">Privacy + Data Security</option>
                                                                                                <option class="level-0" value="1457651">Product Liability + Class Action</option>
                                                                                                <option class="level-0" value="1465361">Rare Disease</option>
                                                                                                <option class="level-0" value="1459071">Regulatory</option>
                                                                                                <option class="level-0" value="1459521">Startup</option>
                                                                                                <option class="level-0" value="1462611">United Kingdom</option>
                                                                                                <option class="level-0" value="1457671">United States</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE (PART 3 OF 3)</a>
                    </li>
                                                                    <li>
                        <a href="fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests.html">FDA Will Once Again Accept Pre-Submissions for All In Vitro Diagnostic Tests</a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 2 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 1 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="senators-call-for-report-on-state-of-psychedelic-research.html">Senators Call for Report on State of Psychedelic Research</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>




</aside>
                </div>
                <!-- #secondary -->
</section>
<!-- end .content-wrap -->
        </div>
        <!-- end .content_container -->
        <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	<p>Unsolicited e-mails and information sent to Morrison &amp; Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison &amp; Foerster. If you are not already a client of Morrison &amp; Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-cookies">
                            <a target="_blank" href="https://www.mofo.com/about/cookies.html">Cookies</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-15', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>